Method and system to remove soluble TNFR1, TNFR2, and IL2 in patients

Details for Australian Patent Application No. 2009227872 (hide)

Owner BioPheresis Technologies, Inc

Inventors Lentz, Rigdon M.

Agent FB Rice

Pub. Number AU-B-2009227872

Parent 2005240082

Filing date 20 October 2009

Wipo publication date 12 November 2009

Acceptance publication date 16 June 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61M 1/34 (2006.01) Suction or pumping devices for medical purposes - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration

Event Publications

5 November 2009 Complete Application Filed

12 November 2009 Application Open to Public Inspection

  Published as AU-B-2009227872

16 June 2011 Application Accepted

  Published as AU-B-2009227872

13 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009227873-Digital marketing optimization

2009227871-Surgical access assembly